Intuitive Surgical, Inc. (NASDAQ:ISRG) has earned an average recommendation of “Buy” from the twenty-two ratings firms that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and seventeen have given a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $554.64.
ISRG has been the topic of several recent research reports. Piper Jaffray Companies upped their price objective on Intuitive Surgical from $613.00 to $625.00 and gave the company an “overweight” rating in a research report on Wednesday, October 31st. BTIG Research restated a “hold” rating on shares of Intuitive Surgical in a research report on Sunday, October 21st. Royal Bank of Canada restated a “hold” rating and issued a $560.00 price objective on shares of Intuitive Surgical in a research report on Friday, October 19th. Raymond James upped their price objective on Intuitive Surgical from $620.00 to $630.00 and gave the company an “outperform” rating in a research report on Friday, October 19th. Finally, Canaccord Genuity upgraded Intuitive Surgical from a “hold” rating to a “buy” rating and upped their price objective for the company from $550.00 to $610.00 in a research report on Friday, October 19th. They noted that the move was a valuation call.
ISRG traded down $5.64 during trading on Monday, reaching $540.04. 95,672 shares of the stock were exchanged, compared to its average volume of 1,093,480. The company has a market cap of $59.35 billion, a price-to-earnings ratio of 75.11, a PEG ratio of 3.49 and a beta of 1.02. Intuitive Surgical has a 1 year low of $359.75 and a 1 year high of $581.12.
In related news, VP Jamie Samath sold 864 shares of the company’s stock in a transaction on Tuesday, October 23rd. The stock was sold at an average price of $499.21, for a total value of $431,317.44. Following the completion of the transaction, the vice president now directly owns 257 shares in the company, valued at $128,296.97. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Mark J. Rubash sold 350 shares of the company’s stock in a transaction on Friday, August 31st. The shares were sold at an average price of $560.00, for a total value of $196,000.00. Following the completion of the transaction, the director now owns 4,316 shares of the company’s stock, valued at $2,416,960. The disclosure for this sale can be found here. Insiders sold 47,086 shares of company stock valued at $24,023,337 over the last quarter. Insiders own 2.20% of the company’s stock.
Institutional investors have recently added to or reduced their stakes in the stock. Adviser Investments LLC acquired a new position in Intuitive Surgical in the second quarter valued at $115,000. Signet Financial Management LLC acquired a new stake in Intuitive Surgical during the second quarter worth about $115,000. Arrow Financial Corp acquired a new stake in Intuitive Surgical during the third quarter worth about $115,000. JNBA Financial Advisors acquired a new stake in Intuitive Surgical during the third quarter worth about $115,000. Finally, Pendal Group Ltd acquired a new stake in Intuitive Surgical during the third quarter worth about $118,000. Hedge funds and other institutional investors own 84.16% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
See Also: How Do I Invest in Dividend Stocks
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.